Metastatic Malignant Germ Cell Tumor: Clinical Trials

2 trials for Metastatic Malignant Germ Cell Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Active not recruiting 1

Follow Metastatic Malignant Germ Cell Tumor: new trials by email Literature Review of Metastatic Malignant Germ Cell Tumor trials Research Report on Metastatic Malignant Germ Cell Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
Audiometric Test, Cisplatin, Computed Tomography - Hearing Loss, Metastatic Malignant Germ Cell Tumor
Phase 1RecruitingCity of Hope Medical Center442026-02-192026-04-17
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
Laboratory Biomarker Analysis, Pembrolizumab, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Carcinoma of Unknown Primary
Phase 2Active not recruitingM.D. Anderson Cancer Center1572016-08-152026-07-17

Narrower conditions

Adrenal Cortex Neoplasms (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Small Cell (1)  ·  Hearing Loss (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms, Unknown Primary (1)  ·  Paraganglioma (1)  ·  Penile Neoplasms (1)  ·  Pheochromocytoma (1)  ·  Seminoma (1)  ·  Testicular Neoplasms (1)  ·  Vascular Neoplasms (1)

Broader conditions

Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Adrenal Cortex Diseases (1)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Cisplatin (1)  ·  Hearing (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Platinum (1)  ·  pembrolizumab (1)  ·  sodium thiosulfate (1)

Sponsors

City of Hope Medical Center (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (2)

Top investigators

Alex Chehrazi-Raffle (1)  ·  Aung Naing (1)

Results publications

PMID 31533818, PMID 32188704, PMID 32303619, PMID 32534809, PMID 33415580, PMID 33427689, PMID 33491277, PMID 33770291, PMID 34241781, PMID 34725215, PMID 35618285, PMID 35999229, PMID 37568622, PMID 40212844, PMID 41143139, PMID 42342409

NIH funding

P30CA033572 (1)